130 related articles for article (PubMed ID: 33234935)
1. False-Positive 18F-Prostate-Specific Membrane Antigen-1007 PET/CT Caused by Hepatic Multifocal Inflammatory Foci.
Ladrón-de-Guevara D; Canelo A; Piottante A; Regonesi C
Clin Nucl Med; 2021 Feb; 46(2):e80-e83. PubMed ID: 33234935
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
Panagiotidis E; Paschali A; Giannoula E; Chatzipavlidou V
Clin Nucl Med; 2019 Jan; 44(1):e46-e48. PubMed ID: 30371591
[TBL] [Abstract][Full Text] [Related]
4. Assessment of malignancy and PSMA expression of uncertain bone foci in [
Vollnberg B; Alberts I; Genitsch V; Rominger A; Afshar-Oromieh A
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3910-3916. PubMed ID: 35482114
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml.
Witkowska-Patena E; Giżewska A; Dziuk M; Miśko J; Budzyńska A; Walęcka-Mazur A
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):343-348. PubMed ID: 31780781
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of
Sprute K; Kramer V; Koerber SA; Meneses M; Fernandez R; Soza-Ried C; Eiber M; Weber WA; Rauscher I; Rahbar K; Schaefers M; Watabe T; Uemura M; Naka S; Nonomura N; Hatazawa J; Schwab C; Schütz V; Hohenfellner M; Holland-Letz T; Debus J; Kratochwil C; Amaral H; Choyke PL; Haberkorn U; Sandoval C; Giesel FL
J Nucl Med; 2021 Feb; 62(2):208-213. PubMed ID: 32817141
[TBL] [Abstract][Full Text] [Related]
7. Intraindividual Comparison of
Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
[TBL] [Abstract][Full Text] [Related]
8. Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007.
Seifert R; Schafigh D; Bögemann M; Weckesser M; Rahbar K
Clin Nucl Med; 2019 Jun; 44(6):e394-e395. PubMed ID: 30889005
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [
Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246
[TBL] [Abstract][Full Text] [Related]
11.
Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
[TBL] [Abstract][Full Text] [Related]
12. Detection Efficacy of
Giesel FL; Knorr K; Spohn F; Will L; Maurer T; Flechsig P; Neels O; Schiller K; Amaral H; Weber WA; Haberkorn U; Schwaiger M; Kratochwil C; Choyke P; Kramer V; Kopka K; Eiber M
J Nucl Med; 2019 Mar; 60(3):362-368. PubMed ID: 30042163
[TBL] [Abstract][Full Text] [Related]
13. 18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer.
Witkowska-Patena E; Giżewska A; Miśko J; Dziuk M
Clin Nucl Med; 2019 Jun; 44(6):e401-e403. PubMed ID: 30932984
[TBL] [Abstract][Full Text] [Related]
14. Biopsy-Proven Diffuse Mediastinal Prostate Cancer Metastases Negative on 18F-Fluorocholine, Diagnosed on 68Ga-PSMA and 18F-PSMA PET/CT.
Chaussé G; Niazi T; Abikhzer GS; Probst SM
Clin Nucl Med; 2017 Oct; 42(10):801-802. PubMed ID: 28719448
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of
Rahbar K; Afshar-Oromieh A; Seifert R; Wagner S; Schäfers M; Bögemann M; Weckesser M
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2055-2061. PubMed ID: 30027419
[TBL] [Abstract][Full Text] [Related]
16. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R
Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451
[TBL] [Abstract][Full Text] [Related]
17. Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT.
Ji X; Wang L; Lin J; Tang K
Clin Nucl Med; 2022 Jan; 47(1):e74-e76. PubMed ID: 34238806
[TBL] [Abstract][Full Text] [Related]
18. Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging
Chen MY; Franklin A; Yaxley J; Gianduzzo T; McBean R; Wong D; Tatkovic A; McEwan L; Walters J; Kua B
BJU Int; 2020 Sep; 126(3):396-401. PubMed ID: 32592330
[TBL] [Abstract][Full Text] [Related]
19. Biochemical Recurrence of Prostate Cancer: Initial Results with [
Giesel FL; Will L; Kesch C; Freitag M; Kremer C; Merkle J; Neels OC; Cardinale J; Hadaschik B; Hohenfellner M; Kopka K; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Apr; 59(4):632-635. PubMed ID: 29419475
[TBL] [Abstract][Full Text] [Related]
20. 18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer.
Liu BL; Hong JJ; Tang K; Lin J; Zheng XW
Clin Nucl Med; 2021 Jul; 46(7):e355-e357. PubMed ID: 33782286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
